Over
Dr Farasat Kazmi is a Consultant Clinical Oncologist specialising in lung cancer, with particular expertise in advanced radiotherapy techniques including Stereotactic Ablative Radiotherapy (SABR). He treats lung cancer across all stages, from early-stage disease to locally advanced and metastatic cancer, using modern radiotherapy alongside chemotherapy, immunotherapy, and precision-targeted therapies guided by molecular profiling.
Dr Kazmi has a strong academic and research background and holds an MSc in Nanomedicine from the University of Oxford. He previously worked in the Early Phase Clinical Trials Unit at the Churchill Hospital, Oxford, where he was involved in first-in-human and novel targeted therapy studies. He is the Principal Investigator on three international lung cancer clinical trials and has played a leading role in Cochrane systematic reviews on genomic-guided cancer therapies, ensuring his clinical practice is firmly grounded in the highest-quality evidence.
He is actively involved in precision oncology, leading institutional initiatives focused on integrating molecular testing and personalised treatment strategies into routine cancer care. His work has been recognised through national and international awards, including competitive oncology research and education grants.
In addition to lung cancer, Dr Kazmi treats gynaecological cancers, including ovarian cancer, and non-melanoma skin cancers.
He is known for his clear communication, calm manner, and patient-centred approach, taking time to explain diagnoses and treatment options and supporting shared decision-making throughout the cancer journey.
Dr Kazmi has a strong academic and research background and holds an MSc in Nanomedicine from the University of Oxford. He previously worked in the Early Phase Clinical Trials Unit at the Churchill Hospital, Oxford, where he was involved in first-in-human and novel targeted therapy studies. He is the Principal Investigator on three international lung cancer clinical trials and has played a leading role in Cochrane systematic reviews on genomic-guided cancer therapies, ensuring his clinical practice is firmly grounded in the highest-quality evidence.
He is actively involved in precision oncology, leading institutional initiatives focused on integrating molecular testing and personalised treatment strategies into routine cancer care. His work has been recognised through national and international awards, including competitive oncology research and education grants.
In addition to lung cancer, Dr Kazmi treats gynaecological cancers, including ovarian cancer, and non-melanoma skin cancers.
He is known for his clear communication, calm manner, and patient-centred approach, taking time to explain diagnoses and treatment options and supporting shared decision-making throughout the cancer journey.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Farasat Kazmi
Opleiding & training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncologie
Carrière & aanstellingen
-
2027-09–2028-08 Junior consultant
Vergunningen & verzekering
Medische licenties
GB — Organización Médica Colegial de España (OMC)
Boardcertificeringen
European Board of Oncologie
Beroepsaansprakelijkheidsverzekering:
Generali Healthcare · 1,000,000 EUR dekking · No claims on file
Uitgevoerde procedures
| Procedure | Code | Levenslang aantal |
|---|---|---|
| GP consultation | 99213 | 2,383 |
| Annual physical exam | 99395 | 825 |
| Vaccination administration | 90471 | 217 |
| Minor procedure (skin) | 17110 | 230 |
Diensten & prijzen
| Dienst | Duur | Modaliteit | Prijs |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 720.00 EUR |
Praktijk, team & in praktijk
Video's
Onderzoek & publicaties
h-index: 5 · i10: 4
-
Long-term follow-up of Oncologie across GB
DOI: 10.5950/euroclin.2026.0 · PMID: 31322945 · geciteerd door 39
-
Validation of clinical scoring in Oncologie
DOI: 10.4876/euroclin.2025.1 · PMID: 36082719 · geciteerd door 165
Uitgenodigde lezingen
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Newmarket · 2023 · oral abstract
Onderscheidingen & lidmaatschappen
Onderscheidingen
- 🏆 Top-rated Oncologie — Newmarket · EuroClinics Patient Choice · 2025 · regional
Lidmaatschappen
- WONCA Europe — Family Doctors — Member · Sinds 2028
- national college of family doctors — Member · Sinds 2028
- European Union of Medical Specialists (UEMS) — Member · Sinds 2028
Artikelen van deze arts
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Voor internationale patiënten
- Coördinator
- Patient liaison · farasat.kazmi@euroclinics.example
Locatie
1 tagPatiëntbeoordelingen
Deel uw ervaring — help andere patiënten de juiste arts te vinden. Schrijf een recensie →
Recente recensies
-
★★★★★ ✓ Geverifieerd Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Geverifieerd Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Geverifieerd Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Vergelijkbare specialisten
Alles bladeren →
Mr Abdulla Alhasso
Oncologie · Glasgow
Dr Alexander McDonald
Oncologie · Glasgow
Dr Amna Sheri
Oncologie · London
Dr Angus Robinson
Oncologie · Horley
Dr Anne Armstrong
Oncologie · Manchester
Dr Ashraf Azzabi
Oncologie · Washington
Dr Clare Green
Oncologie · Winchester
Dr Desmond Yip
Oncologie · Garran